Clinical Trial Update: Intravenous Immunoglobulin for Unverricht-Lundborg Disease. [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating intravenous immunoglobulin for Unverricht-Lundborg disease; the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unverricht-lundborg Disease

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale di Mantova | Conditions: Unverricht-Lundborg Disease | Phase 3 | Status: UNKNOWN